Shanghai Henlius Biotech Inc. (HKG: 2696) announced it has received regulatory clearance in Australia to...
Shanghai Henlius Biotech Inc. (HKG: 2696) announced that the Phase III international multicenter clinical study...
Servier Group announced a multi-target research collaboration with the n-Lorem Foundation, a non-profit research organization...
Shanghai Juncell Therapeutics Co., Ltd. announced it has published its prospectus and filed for listing...
Everest Medicines (HKG: 1952) announced it has struck a licensing agreement with U.S. firm Dimerix...
Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA: 688266) announced that the National Medical Products Administration (NMPA)...
Hinova Pharmaceuticals Inc. (SHA: 688302) announced that final analysis results from the Phase IIa clinical...
Jiangsu Chia Tai Tianqing Pharmaceutical Co., Ltd. (CTTQ), a subsidiary of Sino Biopharmaceutical Limited (HKG:...
Harbour BioMed (HKG: 2142) announced it will co-establish, together with U.S. biotechnology company BioMap, a...
Bristol-Myers Squibb (BMS, NYSE: BMY) announced that China’s National Medical Products Administration (NMPA) has granted...
ZERO Prostate Cancer, the leading prostate cancer organization in the United States, announced on June...
Gilead Sciences, Inc. (NASDAQ: GILD) announced that the U.S. Food and Drug Administration (FDA) has...
Johnson & Johnson (J&J, NYSE: JNJ) announced a $1+ billion investment in Jacksonville, Florida, to...
Lynk Pharmaceuticals Co., Ltd. announced it has published its prospectus and formally applied for listing...
Shanghai Leadingtac Pharmaceutical Co., Ltd. announced that China’s National Medical Products Administration (NMPA) has granted...
Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196; HKG: 2196) announced that China’s National Medical Products...
TriApex Laboratories Co., Ltd. announced it has published its prospectus and formally applied for listing...
Ningbo Sanxing Medical Electric Co., Ltd. announced it has filed its prospectus for listing on...
Nanjing Gritpharma Co., Ltd. announced it has received marketing approval from China’s National Medical Products...
Baheal Pharma Group (SHE: 301015) announced a strategic partnership with Jinan Junxin Cancer Hospital to...